
Pulse Biosciences PLSE
€ 20.90
-10.22%
Quartalsbericht 2026-Q1
hinzugefügt 14.05.2026
Pulse Biosciences Langfristiger Schuldenstrom 2011-2026 | PLSE
Langfristiger Schuldenstrom Jährlich Pulse Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.57 M | 1.36 M | 1.06 M | 896 K | 774 K | 542 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.57 M | 542 K | 1.03 M |
Langfristiger Schuldenstrom anderer Aktien in der Medizinische Instrumente
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
37.8 M | $ 59.78 | -0.99 % | $ 11.9 B | ||
|
iRhythm Technologies
IRTC
|
16.7 M | $ 114.31 | 0.13 % | $ 3.66 B | ||
|
ICU Medical
ICUI
|
13.8 M | $ 119.39 | -2.93 % | $ 2.94 B | ||
|
Intuitive Surgical
ISRG
|
39 M | $ 421.75 | -1.47 % | $ 151 B | ||
|
Repro Med Systems
KRMD
|
413 K | $ 3.93 | -1.26 % | $ 182 M | ||
|
Alcon
ALC
|
80 M | $ 63.78 | -0.34 % | $ 40.4 B | ||
|
LeMaitre Vascular
LMAT
|
2.94 M | $ 97.38 | -2.13 % | $ 2.2 B | ||
|
Masimo Corporation
MASI
|
21.4 M | $ 178.49 | 0.08 % | $ 9.51 B | ||
|
Ekso Bionics Holdings
EKSO
|
441 K | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
39 M | $ 23.4 | -1.89 % | $ 3.93 B | ||
|
electroCore
ECOR
|
375 K | $ 6.04 | -6.07 % | $ 51.2 K | ||
|
Haemonetics Corporation
HAE
|
8.11 M | $ 56.73 | -0.68 % | $ 2.86 B | ||
|
Isoray
ISR
|
623 K | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
1.31 M | $ 143.49 | 0.93 % | $ 6.95 B | ||
|
STAAR Surgical Company
STAA
|
5.87 M | $ 32.41 | 1.25 % | $ 1.61 B | ||
|
STERIS plc
STE
|
34.2 M | $ 211.83 | -1.92 % | $ 20.9 B | ||
|
Teleflex Incorporated
TFX
|
100 M | $ 130.52 | 0.18 % | $ 5.82 B | ||
|
InfuSystem Holdings
INFU
|
349 K | $ 8.65 | 0.46 % | $ 179 M | ||
|
Microbot Medical
MBOT
|
296 K | $ 1.88 | 1.35 % | $ 86.1 M | ||
|
Milestone Scientific
MLSS
|
130 K | $ 0.33 | -2.77 % | $ 27.1 M | ||
|
Merit Medical Systems
MMSI
|
10.9 M | $ 61.59 | -1.55 % | $ 3.64 B | ||
|
Utah Medical Products
UTMD
|
60 K | $ 63.27 | -0.68 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
22.7 M | $ 303.95 | 1.25 % | $ 22 B | ||
|
DENTSPLY SIRONA
XRAY
|
47 M | $ 9.99 | -3.99 % | $ 1.99 B | ||
|
Retractable Technologies
RVP
|
286 K | $ 0.65 | -5.8 % | $ 19.5 M | ||
|
Predictive Oncology
POAI
|
654 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
2.24 M | $ 20.35 | -3.4 % | $ 972 M | ||
|
Stereotaxis
STXS
|
642 K | $ 1.89 | -3.08 % | $ 172 M | ||
|
Baxter International
BAX
|
81 M | $ 17.34 | -2.47 % | $ 8.9 B | ||
|
ResMed
RMD
|
21.9 M | $ 202.44 | -0.01 % | $ 29.6 B | ||
|
AtriCure
ATRC
|
1.73 M | $ 28.16 | 0.04 % | $ 1.34 B | ||
|
Harvard Bioscience
HBIO
|
1.52 M | $ 5.37 | -2.72 % | $ 238 M | ||
|
NeuroMetrix
NURO
|
107 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
1.84 M | $ 10.79 | -2.18 % | $ 441 M | ||
|
Becton, Dickinson and Company
BDX
|
135 M | $ 143.35 | -0.77 % | $ 41.2 B | ||
|
Nephros
NEPH
|
386 K | $ 3.23 | -1.1 % | $ 34.3 M | ||
|
OraSure Technologies
OSUR
|
2.16 M | $ 3.07 | 3.9 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
21.6 M | $ 103.63 | 0.24 % | $ 5.83 M |